期刊文献+

宫颈癌高发区新疆墨玉县有宫颈癌家族史的维吾尔族妇女人类白细胞抗原等位基因多态性的分布 被引量:11

Distribution of HLA-DRB1 allele polymorphism in the Uyghur women with family history of cervical cancer
原文传递
导出
摘要 目的初步探讨有宫颈癌家族史的妇女人类白细胞抗原(HLA)-DRBl等位基因多态性的分布情况,为宫颈癌高危人群的检测及追踪提供理论依据。方法采用聚合酶链反应-序列特异性引物法检测1000例新疆和田地区墨玉县喀尔赛乡维吾尔族妇女血液中HLA-DRBl的13个等位基因。结果等位基因HIJA-DRBl。15在有宫颈癌家族史、母亲有宫颈癌病史和其他亲属有宫颈癌病史的妇女中出现的频率分别为17.3%、18.0%和17.O%,均明显高于无宫颈癌家族史的妇女(9.7%,均P〈0.05)。HLA-DRBl*04在有宫颈癌家族史和除了母亲以外其他亲属有宫颈癌病史的妇女中出现的频率分别为16.8%和20.7%,明显高于无宫颈癌家族史的妇女(12.7%,均P〈0.05)。HIJA-DRBls03在有宫颈癌家族史和在除了母亲以外其他亲属有宫颈癌病史的妇女中出现的频率分别为2.6%和1.1%,明显低于无宫颈癌家族史的妇女(6.3%,均P〈0.01)。HLA-DRBl。12在有宫颈癌家族史和母亲有宫颈癌病史的妇女中出现的频率分别为2.3%和1.5%,明显低于无宫颈癌家族史妇女(5.7%,均P〈0.05)。HIA-DRBl}14在有宫颈癌家族史和母亲有宫颈癌病史的妇女中出现的频率分别为5.4%和3.O%,明显低于无宫颈癌家族史妇女(8.4%,均P〈0.05)。结论新疆墨玉县妇女有宫颈癌家族史者HLA-DRBl等位基因的分布与南疆维吾尔族宫颈癌妇女的HLA-DRBl等位基因的分布有相同点也存在一定差异。HLA易感基因及保护基因的研究在维吾尔族宫颈癌高发区宫颈癌高危人群及易感人群的检测中起一定的作用。 Objective To study the distribution of HLA-DRB1 allele polymorphism in Uyghur women with family history of cervical cancer, and provide theoretical evidence for detection and follow-up of high risk persons for cervical cancer by detection of HLA-DRB1 allele polymorphism. Methods The HLADRB1 13 alleles were detected in 1000 Uyghur women, all from Hotan Moyu county Karsay village by using polymerase chain reaction sequence-specific oligonucleotide (PCR-SSO) assay. Results The frequencies of HLA-DRB1 * 15 in women with family history of cervical cancer ( 17.3% ) , mother ( 18.0% ) and other relatives except mother ( 17.0% ) who had suffered from cervical cancer were significantly hi^her than that in the control group (9.7%, all P 〈0.05). The frequencies of HLA-DRB1 04 in women with family history ( 16.8% ) and other relatives except mother (20.7%) were significantly higher than that in the control group ( 12.7%, all P 〈0.05). The frequencies of HLA-DRB1 * 03 in women with family history (2.6%)and other relatives except mother ( 1.1% ) were significantly lower than that in the control group (6.3% , all P 〈0.01). The frequencies of HLA-DRB1 * 12 in women with family history of cervical cancer (2.3%) and mother suffered from cervical cancer (1.5%) were significantly lower than that in the control group (5.7%, all P 〈0.05). The frequencies of HLA-DRB1 * 14 in women with family history of cervical cancer (5.4%) and mother who suffered from cervical cancer (3.0%) were significantly lower than that in the control group (8.4%, all P 〈 0.05 ). Conclusions There are similarity and difference in distribution of HLA-DRB1 allele polymorphisms between the Uyghur women with family history of cervical cancer from Hotan Moyu county and those from southern Xingjiang area. In general, the distribution of HLA-DRB1 allele polymorphism in women with family history of cervical cancer is similar to that reported in abroad. The results of this study support the role of susceptible and protective HLA gene detection in screening high risk persons for this cancer among Uyghur women from cervical cancer high risk areas in Xinjiang.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2012年第4期272-277,共6页 Chinese Journal of Oncology
基金 国家自然科学基金(30760222)
关键词 宫颈肿瘤 多态性 单核苷酸 人类白细胞抗原 维吾尔族 Uterine cervical neoplasms Polymorphism, single nucleotide Humanleukocyte antigen Uyghur
  • 相关文献

参考文献17

二级参考文献121

共引文献132

同被引文献104

  • 1陈华,凌娜.环氧合酶-2和碱性成纤维细胞生长因子表达与宫颈癌的相关性研究[J].中国生化药物杂志,2014,34(6):87-90. 被引量:7
  • 2李炜修,郑全庆,王平,李燕琴,陈广华.宫颈正常与宫颈癌组织傅里叶变换红外光谱的初步研究[J].光谱学与光谱分析,2006,26(10):1833-1837. 被引量:13
  • 3凌斌.子宫颈癌诊断与治疗的新进展[J].中国实用妇科与产科杂志,2007,23(1):23-25. 被引量:67
  • 4曾索,丁显平,倪虹,曾梅,李小波.荧光定量PCR法在人类宫颈癌RNA干扰中的应用[J].重庆大学学报(自然科学版),2007,30(12):64-67. 被引量:1
  • 5Bello BD, Spinillo A, Alberizzi P, et al. Cervical infections by multiple human papillomavirus ( HPV) genotypes : prevalence and impact on the risk of precancerous epithelial lesions [J] . J Med Virol, 2009 , 81 (4) : 703 -712.
  • 6Khan K,Curtis CR,Ekwueme DU, et al. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs [J] . Cancer, 2008, 113 (10 Suppl) : 3004-3012.
  • 7WHO. Comprehensive cervical cancer control : a guide to essential practice [ M] . Switzerland: WHO, 2006: 79 - 124.
  • 8Beck S, Aguado B, Bahram S, et a1. Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium[J]. Nature, 1999, 401 (6756) :921-923 ..
  • 9Taneja V, David CS. Role of HLA class II genes in sus?cepti hili t y / res i stance to inflamma to ry arthri tis: s tudi es with humanized mice [J]. Immuno1 Rev, 2010,233 (1) : 62-78.
  • 10Donaldson PT, Ho S, Williams R, et a1. HLA class II al?leles in Chinese patients with hepatocellular carcinoma [J]. Liver, 2001 ,21 (2) : 143-148.

引证文献11

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部